CIMA Healthcare has developed a unique antiseptic formula that
allows patients to address common cuticle infections in hand
and toe nails. This proprietary formulation has been named
CUTIMAX™
CIMA is currently conducting clinical trials of CUTIMAX™ to
determine the efficacy of this sanitizer in the real world
environment.
As a derivative of CUTIMAX™ CIMA has identified other
opportunities for this compound and is currently investing its
resources in converting this formulation into a sanitizer gel.
This gel will have antibacterial properties that will last for a
period of 8 to 12 hours instead of the normal 20-30 minute
sanitizing period that products on the market currently provide.
These products are manufactured in a FDA Registered Facility
following cGMP guidelines.
allows patients to address common cuticle infections in hand
and toe nails. This proprietary formulation has been named
CUTIMAX™
CIMA is currently conducting clinical trials of CUTIMAX™ to
determine the efficacy of this sanitizer in the real world
environment.
As a derivative of CUTIMAX™ CIMA has identified other
opportunities for this compound and is currently investing its
resources in converting this formulation into a sanitizer gel.
This gel will have antibacterial properties that will last for a
period of 8 to 12 hours instead of the normal 20-30 minute
sanitizing period that products on the market currently provide.
These products are manufactured in a FDA Registered Facility
following cGMP guidelines.
In addition to proprietary formulas,
CIMA Healthcare offers the following
Outsourcing Alternatives to potential
customers:
CIMA Healthcare offers the following
Outsourcing Alternatives to potential
customers:
 | Contract Manufacturing | |
| Contract Packaging | |
| Promotional Packaging | |
| Analytical Testing | |
| Process Rework and | |
| 100% Visual Inspection | |
Our Products
 |  |  |  |
CIMA Healthcare Products Corp.
